These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4324836)
1. Chlorpropamide and tolbutamide inhibition of adenosine 3'5' cyclic monophosphate phosphodiesterase. Brooker G; Fichman M Biochem Biophys Res Commun; 1971 Mar; 42(5):824-8. PubMed ID: 4324836 [No Abstract] [Full Text] [Related]
2. Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide. Goldfine ID; Perlman R; Roth J Nature; 1971 Dec; 234(5327):295-7. PubMed ID: 4333163 [No Abstract] [Full Text] [Related]
3. Distribution of tolbutamide and chlorpropamide after administration to non-diabetic rats. Nistrup Madsen S; Fog-Moller F; Persson I Eur J Pharmacol; 1971; 13(3):374-80. PubMed ID: 5577500 [No Abstract] [Full Text] [Related]
4. The metabolism of adenosine 3',5'-cyclic phosphate. II. Some properties of adenosine-3',5'-cyclic-phosphate phosphodiesterase from the rat kidney. Dousa T; Rychlík I Biochim Biophys Acta; 1970 Mar; 204(1):10-7. PubMed ID: 4314465 [No Abstract] [Full Text] [Related]
5. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227 [TBL] [Abstract][Full Text] [Related]
7. [Influence of hydrochlorothiazide and other sulfamoyl diuretics on the activity of 3',5'-AMP phosphodiesterase in rat kidney]. Senft G; Munske K; Schultz G; Hoffmann M Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(4):344-59. PubMed ID: 4301852 [No Abstract] [Full Text] [Related]
8. An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells. Manganiello V; Vaughan M J Clin Invest; 1972 Oct; 51(10):2763-7. PubMed ID: 4341439 [TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Marquis NR; Vigdahl RL; Tavormina PA Biochem Biophys Res Commun; 1969 Sep; 36(6):965-72. PubMed ID: 4310150 [TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP stimulation and inhibition of cyclic AMP phosphodiesterase from thymic lymphocytes. Franks DJ; Macmanus JP Biochem Biophys Res Commun; 1971 Mar; 42(5):844-9. PubMed ID: 4324837 [No Abstract] [Full Text] [Related]
11. Inhibition of a cyclic nucleotide phosphodiesterase from beef heart by catecholamines and related compounds. Goren EN; Rosen OM Mol Pharmacol; 1972 May; 8(3):380-4. PubMed ID: 4339291 [No Abstract] [Full Text] [Related]
12. Steroidogenesis in isolated adrenal cells of rat. II. Effect of caffeine on ACTH and cyclic nucleotide-induced steroidogenesis and its relation to cyclic nucleotide phosphodiesterase (PDE). Kitabchi AE; Wilson DB; Sharma RK Biochem Biophys Res Commun; 1971 Aug; 44(4):898-904. PubMed ID: 4331040 [No Abstract] [Full Text] [Related]
13. Paper chromatography combined with phosphodiesterase treatment in the determination of radioactively labelled cyclic 3',5'-adenosine monophosphate. Osnes JB; Christoffersen T; Morland J; Oye I J Chromatogr; 1972 Apr; 67(1):139-47. PubMed ID: 4336978 [No Abstract] [Full Text] [Related]
14. Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs. Huang M; Shimizu H; Daly JW J Med Chem; 1972 May; 15(5):462-6. PubMed ID: 4402484 [No Abstract] [Full Text] [Related]
15. Evidence for and some properties of a 3', 5'-cyclic AMP phosphodiesterase inhibitor in potato. Shimoyama M; Kawai M; Tanigawa Y; Ueda I Biochem Biophys Res Commun; 1972 Apr; 47(1):59-65. PubMed ID: 4337428 [No Abstract] [Full Text] [Related]
16. Presence of two 3'-5'-cyclic AMP phosphodiesterases in rat kidney and frog bladder epithelial cells extracts. Jard S; Bernard M Biochem Biophys Res Commun; 1970 Nov; 41(3):781-8. PubMed ID: 4320283 [No Abstract] [Full Text] [Related]
17. Adenosine 3',5'-cyclic phosphate phosphodiesterase of corpus luteum. Stansfield DA; Horne JR; Wilkinson GH Biochim Biophys Acta; 1971 Feb; 227(2):413-8. PubMed ID: 4323860 [No Abstract] [Full Text] [Related]
18. The regulatory role of phosphodiesterase in adenosine cyclic 3',5'-monophosphate mediated ACTH. Ng SS KONG YC Experientia; 1971; 27(11):1257-8. PubMed ID: 4332432 [No Abstract] [Full Text] [Related]
19. Adenosine 3':5'-cyclic monophosphate phosphodiesterase in skin. I. Measurement and properties. Mier PD; Urselmann E Br J Dermatol; 1972 Feb; 86(2):141-6. PubMed ID: 4335966 [No Abstract] [Full Text] [Related]
20. [A new hypoglycemic sulfonamide: AN1324]. Vignalou J; Beck H Presse Med (1893); 1968 Oct; 76(38):1827-8. PubMed ID: 5737547 [No Abstract] [Full Text] [Related] [Next] [New Search]